Home » News and events » Fighting cancer from within: Using the body’s own immune system to tackle cancer 

Fighting cancer from within: Using the body’s own immune system to tackle cancer 

Digital representation of cancer cells

Research theme

Cancer inflammation

People involved

Dr Claire Palles

Group Leader

Promotional banner for the online research talk 'Fighting cancer from within: Using the body's own immune system to tackle cancer.' Text: How do immunotherapy drugs work? What are their side effects? Discover how our research is exploring ways to improve treatments for future cancer patients. Calendar icon: Thursday 3 April, 6-7pm. Picture of Dr Claire Palles, Associate Professor at the University of Birmingham.

How do immunotherapy cancer drugs work? What are their side effects? Join this free short talk followed by Q&A to discover how our research is exploring ways to improve treatments for future cancer patients – no science knowledge needed

Immunotherapy is a type of cancer treatment that uses the body’s own immune system to fight cancer. 

Immunotherapy drugs aim to wake up the patients’ immune system to destroy cancer cells and are now given regularly to patients with lung cancer, aggressive skin cancers called melanoma and patients with other cancer types too. These drugs work well in many patients keeping cancer at bay, sometimes for many years. Unfortunately however, a large proportion of patients treated with these drugs experience serious side effects. These side effects can be hard to manage, affect patients’ quality of life and in some, rare cases, can be fatal. At the moment, it is difficult to predict who will experience side effects.  

In this talk, Claire will uncover how immunotherapy drugs work, explore the common and rare side effects and share how research led by the University of Birmingham is exploring ways to understand and reduce these severe side effects to improve treatments for future cancer patients. 

This online talk is part of our free webinar series “Your health, our research: Short talks, big impact